vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and First Bancorp, Inc (FNLC). Click either name above to swap in a different company.

CODEXIS, INC. is the larger business by last-quarter revenue ($38.9M vs $25.8M, roughly 1.5× First Bancorp, Inc). First Bancorp, Inc runs the higher net margin — 39.4% vs 24.7%, a 14.7% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 17.5%). First Bancorp, Inc produced more free cash flow last quarter ($34.6M vs $19.6M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 18.1%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.

CDXS vs FNLC — Head-to-Head

Bigger by revenue
CDXS
CDXS
1.5× larger
CDXS
$38.9M
$25.8M
FNLC
Growing faster (revenue YoY)
CDXS
CDXS
+63.8% gap
CDXS
81.3%
17.5%
FNLC
Higher net margin
FNLC
FNLC
14.7% more per $
FNLC
39.4%
24.7%
CDXS
More free cash flow
FNLC
FNLC
$15.0M more FCF
FNLC
$34.6M
$19.6M
CDXS
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
18.1%
FNLC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDXS
CDXS
FNLC
FNLC
Revenue
$38.9M
$25.8M
Net Profit
$9.6M
$10.2M
Gross Margin
94.8%
Operating Margin
27.1%
48.1%
Net Margin
24.7%
39.4%
Revenue YoY
81.3%
17.5%
Net Profit YoY
192.5%
39.7%
EPS (diluted)
$0.13
$0.91

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
FNLC
FNLC
Q4 25
$38.9M
$25.8M
Q3 25
$8.6M
$24.5M
Q2 25
$15.3M
$22.5M
Q1 25
$7.5M
$21.8M
Q4 24
$21.5M
$22.0M
Q3 24
$12.8M
$20.5M
Q2 24
$8.0M
$19.2M
Q1 24
$17.1M
$18.5M
Net Profit
CDXS
CDXS
FNLC
FNLC
Q4 25
$9.6M
$10.2M
Q3 25
$-19.6M
$9.1M
Q2 25
$-13.3M
$8.1M
Q1 25
$-20.7M
$7.1M
Q4 24
$-10.4M
$7.3M
Q3 24
$-20.6M
$7.6M
Q2 24
$-22.8M
$6.2M
Q1 24
$-11.5M
$6.0M
Gross Margin
CDXS
CDXS
FNLC
FNLC
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
FNLC
FNLC
Q4 25
27.1%
48.1%
Q3 25
-220.3%
45.2%
Q2 25
-83.9%
43.7%
Q1 25
-271.6%
39.3%
Q4 24
-34.2%
39.5%
Q3 24
-129.0%
44.6%
Q2 24
-284.9%
38.8%
Q1 24
-69.6%
39.3%
Net Margin
CDXS
CDXS
FNLC
FNLC
Q4 25
24.7%
39.4%
Q3 25
-228.1%
37.0%
Q2 25
-86.6%
35.8%
Q1 25
-274.3%
32.5%
Q4 24
-48.4%
33.1%
Q3 24
-160.8%
36.9%
Q2 24
-285.2%
32.1%
Q1 24
-67.4%
32.5%
EPS (diluted)
CDXS
CDXS
FNLC
FNLC
Q4 25
$0.13
$0.91
Q3 25
$-0.22
$0.81
Q2 25
$-0.16
$0.72
Q1 25
$-0.25
$0.63
Q4 24
$-0.12
$0.66
Q3 24
$-0.29
$0.68
Q2 24
$-0.32
$0.55
Q1 24
$-0.16
$0.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
FNLC
FNLC
Cash + ST InvestmentsLiquidity on hand
$78.2M
Total DebtLower is stronger
$40.1M
$95.5M
Stockholders' EquityBook value
$50.5M
$283.1M
Total Assets
$147.8M
$3.2B
Debt / EquityLower = less leverage
0.79×
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
FNLC
FNLC
Q4 25
$78.2M
Q3 25
$58.7M
Q2 25
$66.3M
Q1 25
$59.8M
Q4 24
$73.5M
Q3 24
$90.3M
Q2 24
$73.2M
Q1 24
$85.5M
Total Debt
CDXS
CDXS
FNLC
FNLC
Q4 25
$40.1M
$95.5M
Q3 25
$39.7M
$95.5M
Q2 25
$39.4M
$95.0M
Q1 25
$29.2M
$70.0M
Q4 24
$28.9M
$95.0M
Q3 24
$28.6M
$95.0M
Q2 24
$28.4M
$70.0M
Q1 24
$28.1M
$70.0M
Stockholders' Equity
CDXS
CDXS
FNLC
FNLC
Q4 25
$50.5M
$283.1M
Q3 25
$38.5M
$274.6M
Q2 25
$55.6M
$265.5M
Q1 25
$49.6M
$259.7M
Q4 24
$66.9M
$252.5M
Q3 24
$73.4M
$256.8M
Q2 24
$61.4M
$244.7M
Q1 24
$79.3M
$242.6M
Total Assets
CDXS
CDXS
FNLC
FNLC
Q4 25
$147.8M
$3.2B
Q3 25
$124.0M
$3.2B
Q2 25
$138.2M
$3.2B
Q1 25
$128.9M
$3.2B
Q4 24
$149.0M
$3.2B
Q3 24
$148.2M
$3.1B
Q2 24
$132.0M
$3.1B
Q1 24
$149.6M
$3.0B
Debt / Equity
CDXS
CDXS
FNLC
FNLC
Q4 25
0.79×
0.34×
Q3 25
1.03×
0.35×
Q2 25
0.71×
0.36×
Q1 25
0.59×
0.27×
Q4 24
0.43×
0.38×
Q3 24
0.39×
0.37×
Q2 24
0.46×
0.29×
Q1 24
0.35×
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
FNLC
FNLC
Operating Cash FlowLast quarter
$20.1M
$37.8M
Free Cash FlowOCF − Capex
$19.6M
$34.6M
FCF MarginFCF / Revenue
50.3%
133.9%
Capex IntensityCapex / Revenue
1.3%
12.5%
Cash ConversionOCF / Net Profit
2.09×
3.72×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M
$55.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
FNLC
FNLC
Q4 25
$20.1M
$37.8M
Q3 25
$-7.7M
$12.9M
Q2 25
$-18.0M
$7.4M
Q1 25
$-13.8M
$2.2M
Q4 24
$-16.5M
$26.0M
Q3 24
$-13.0M
$9.8M
Q2 24
$-12.2M
$6.4M
Q1 24
$-7.8M
$-1.5M
Free Cash Flow
CDXS
CDXS
FNLC
FNLC
Q4 25
$19.6M
$34.6M
Q3 25
$-7.9M
$12.6M
Q2 25
$-20.5M
$7.2M
Q1 25
$-15.1M
$828.0K
Q4 24
$-18.2M
$24.6M
Q3 24
$-14.0M
$9.6M
Q2 24
$-12.6M
$6.3M
Q1 24
$-8.9M
$-1.8M
FCF Margin
CDXS
CDXS
FNLC
FNLC
Q4 25
50.3%
133.9%
Q3 25
-91.7%
51.4%
Q2 25
-133.6%
32.1%
Q1 25
-199.6%
3.8%
Q4 24
-85.0%
111.7%
Q3 24
-109.0%
47.0%
Q2 24
-157.5%
32.9%
Q1 24
-52.2%
-9.8%
Capex Intensity
CDXS
CDXS
FNLC
FNLC
Q4 25
1.3%
12.5%
Q3 25
2.1%
1.2%
Q2 25
16.4%
0.6%
Q1 25
16.7%
6.2%
Q4 24
8.3%
6.7%
Q3 24
7.8%
0.5%
Q2 24
5.0%
0.3%
Q1 24
6.6%
1.8%
Cash Conversion
CDXS
CDXS
FNLC
FNLC
Q4 25
2.09×
3.72×
Q3 25
1.42×
Q2 25
0.91×
Q1 25
0.31×
Q4 24
3.58×
Q3 24
1.29×
Q2 24
1.03×
Q1 24
-0.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons